Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (AdenONCO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02403193
Recruitment Status : Completed
First Posted : March 31, 2015
Last Update Posted : January 12, 2022
Sponsor:
Collaborators:
Novartis
H. Lee Moffitt Cancer Center and Research Institute
Information provided by (Responsible Party):
Palobiofarma SL

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2021
Actual Study Completion Date : November 24, 2021